This federal contract award is for the supply of 135 doses of Fluorine-18 Fluorodeoxyglucose (F18 FDG) radiopharmaceutical, up to 15 millicuries per dose, to the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract has a ceiling value of $24,942.60 and is a firm fixed-price purchase order with an ultimate completion date of April 30, 2025. The prime contractor is Cardinal Health 414, LLC, a subsidiary of...
Cardinal Health 414, LLC has been awarded a firm fixed price purchase order contract valued at $27,037.50 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide up to 15 millicuries of fluorodeoxyglucose (FDG), a radioactive chemical used for imaging and scans, with delivery by January 17, 2025. No set-aside designation was applied. This award supports the NIH's medical research efforts through the delivery of radiopharmaceuticals by Cardinal...
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, Nphs Division, doing business as Cardinal Health 414, Inc. The contract is for the delivery of the radiopharmaceutical Fludeoxyglucose (F-18 FDG) to the Walter Reed National Military Medical Center in Bethesda, Maryland. The contract has a ceiling value of $186,125.00 and a performance period ending on June 15, 2024. Cardinal Health 414 is a major supplier of radiopharmaceuticals and...
This federal contract award is for the procurement of F-18 FDG (fluorine-18 fluorodeoxyglucose), a radioactive chemical used for imaging and scans, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), a civilian federal agency. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract is a firm fixed-price purchase order with a ceiling value of...
This federal contract award, with ID 75N93022P00218, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $11,355.75 firm fixed-price purchase order is for the delivery of 100 doses of F-18 FDG UD, up to 15 mCi, with a completion date of October 20, 2022. Cardinal Health 414 is a major provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to...
This is a delivery order contract awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $65,053.00 firm fixed-price contract is for the supply of an F-18 FDG in shielded delivery and administration system, which is a radiopharmaceutical product used in nuclear medicine imaging procedures. Cardinal Health 414 is a major provider of radiopharmaceuticals and other specialty medical products to various federal...
This is a $90,735.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of PET/CT radiopharmaceutical imaging supplies. The contract does not have a set-aside designation. Cardinal Health 414 is an established healthcare product supplier that has been awarded numerous federal contracts, primarily from the VA, Defense Health Agency, and National...
This federal contract award, valued at $1,275,519.30, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract is for the supply of FDG isotopes, including bulk doses, unit doses, and sodium fluoride, to support the VA Greater Los Angeles Healthcare System. The contract has a performance period of five years, from the base year beginning April 1, 2024 through March 31, 2029. It was...
This federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is for the supply of radiopharmaceuticals, radioactive isotopes, and specialized pharmaceutical products to the National Institutes of Health (NIH) Clinical Center. The $13,531.56 firm fixed-price purchase order has an ultimate completion date of April 30, 2020. Cardinal Health 414 is a large, for-profit limited liability company with extensive experience providing critical nuclear medicine products...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceuticals, radioactive isotopes, diagnostic imaging agents, and specialty pharmaceuticals to federal healthcare agencies. The contract, awarded by the Office of the Chief Operating Officer, has a ceiling value of $24,283.80 and is a firm fixed-price purchase order with a completion date of June 8, 2016. Cardinal Health 414 primarily supports nuclear medicine,...